This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of Knut Bartl
Introduction
Knut Bartl is a notable inventor based in Wielenbach, Germany. He has made significant contributions to the field of nucleic acid detection, showcasing his expertise and innovative spirit. His work has implications for various applications in biotechnology and diagnostics.
Latest Patents
Knut Bartl holds a patent for a specific and sensitive nucleic acid detection method. This method involves the production of multiple amplificates of a nucleic acid section using two primers. One primer binds to a binding sequence A of the nucleic acid, while the other binds to a complementary sequence C' located in the 3′ direction from A. The process includes contacting the amplificates with a probe that can bind to a sequence B located between sequences A and C, allowing for the detection of hybrid formation between the amplificate and probe.
Career Highlights
Knut Bartl is associated with Roche Diagnostics GmbH, a leading company in the field of diagnostics. His work at Roche has allowed him to contribute to advancements in medical technology and improve diagnostic methods. His innovative approach has led to the development of techniques that enhance the accuracy and sensitivity of nucleic acid detection.
Collaborations
Knut Bartl has collaborated with esteemed colleagues such as Gerd Haberhausen and Henrik Orum. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.
Conclusion
Knut Bartl's contributions to nucleic acid detection exemplify the impact of innovative thinking in biotechnology. His patent and work at Roche Diagnostics GmbH highlight the importance of advancements in medical diagnostics. Through collaboration and dedication, he continues to push the boundaries of scientific discovery.